If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Florence Ader is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
  • Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

    Gaborit, B., Vanhove, B., Vibet, M. A., Le Thuaut, A., Lacombe, K., Dubee, V., Ader, F., Ferre, V., Vicaut, E., Orain, J., Le Bras, M., Omnes, A., Berly, L., Jobert, A., Morineau-Le Houssine, P., Botturi, K., Josien, R., Flet, L., Degauque, N., Brouard, S. & 35 others, Duvaux, O., Poinas, A., Raffi, F., Dailly, E., Guimard, T., Braudeau, C., Malvy, D., Faucher, J. F., Illes Hajnal, G., Vareil, M. O., Roncato-Saberam, M., Vacher, L., Biron, C., Lefebvre, M., Gallot, G., Le Turnier, P., Deschanvres, C., Lecomte, R., Chauveau, M., Lecompte, A. S., Grégoire, M., Bellouard, R., Deslandes, G., Ouazene, Z., Bollens, D., Chiarabani, T., Krause-Le Garrec, J., Becker, A., Chauvelot, P., Conrad, A., Ferry, T., Miailhes, P., Pouderoux, C., Roux, S. & Triffault-Fillit, C., 1 Dec 2021, In: Trials. 22, 1

    Research output: Contribution to journalArticlepeer-review

    Open Access
    1 Scopus citations
  • Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (Covid-19)

    Dupont, D., Menotti, J., Turc, J., Miossec, C., Wallet, F., Richard, J. C., Argaud, L., Paulus, S., Wallon, M., Ader, F. & Persat, F., 1 Jan 2021, In: Medical Mycology. 59, 1

    Research output: Contribution to journalArticlepeer-review

    Open Access
    12 Scopus citations
  • Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response

    Le, M. P., Peiffer-Smadja, N., Guedj, J., Neant, N., Mentre, F., Ader, F., Yazdanpanah, Y., Peytavin, G., Ader, F., Yazdanpanah, Y., Mentre, F., Lescure, F. X., Peiffer-Smadja, N., Bouadma, L., Poissy, J., Timsit, J. F., Lina, B., Morfin-Sherpa, F., Peytavin, G., Burdet, C. & 32 others, Laouenan, C., Belhadi, D., Dupont, A., Basli, B., Chair, A., Laribi, S., Level, J., Schneider, M., Tellier, M. C., Dechanet, A., Couffin-Cadiergues, S., Delmas, C., Esperou, H., Fougerou, C., Gelley, A., Moinot, L., Wittkop, L., Cagnot, C., Diallo, A., Le Mestre, S., Lebrasseur-Longuet, D., Mercier, N., Petrov-Sanchez, V., Icard, V., Leveau, B., Guillon, J., Taburet, A. M., Noret, M., D'Ortenzio, E., Puechal, O., Saillard, J. & Semaille, C., 1 Jan 2021, In: Journal of Antimicrobial Chemotherapy. 76, 1

    Research output: Contribution to journalArticlepeer-review

  • Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results

    Pan, H., Peto, R., Henao‑Restrepo, AM. M., Preziosi, MP. P., Sathiyamoorthy, V., Karim, Q. A., Alejandria, M. M., García, C. H., Kieny, MP. P., Malekzadeh, R., Murthy, S., Srinath Reddy, K., Periago, M. R., Hanna, P. A., Ader, F., Al‑Bader, A. M., Alhasawi, A., Allum, E., Alotaibi, A., Alvarez‑Moreno, C. A. & 54 others, Appadoo, S., Asiri, A., Aukrust, P., Barratt‑Due, A., Bellani, S., Branca, M., Cappel‑Porter, H. B. C., Cerrato, N., Chow, T. S., Como, N., Eustace, J., García, P. J., Godbole, S., Gotuzzo, E., Griskevicius, L., Hamra, R., Hassan, M., Hassany, M., Hutton, D., Irmansyah, I., Jancoriene, L., Kirwan, J., Kumar, S., Lennon, P., Lopardo, G., Lydon, P., Magrini, N., Maguire, T., Manevska, S., Manuel, O., McGinty, S., Medina, M. T., Mesa Rubio, M. L., Miranda‑Montoya, M. C., Nel, J., Nunes, E. P., Perola, M., Portolés, A., Rasmin, M. R., Raza, A., Rees, H., Reges, P. P. S., Rogers, C. A., Salami, K., Salvadori, M. I., Sinani, N., Sterne, J. A. C., Stevanovikj, M., Tacconelli, E., Tikkinen, K. A. O., Trelle, S., Zaid, H., Røttingen, JA. A. & Swaminathan, S., 11 Feb 2021, In: New England Journal of Medicine. 384, 6

    Research output: Contribution to journalArticlepeer-review

    Open Access
    221 Scopus citations
  • Type-I Interferon assessment in 45 minutes using the FilmArray® PCR platform in SARS-CoV-2 and other viral infections

    Mommert, M., Perret, M., Hockin, M., Viel, S., Belot, A., Richard, J. C., Mezidi, M., Fassier, J. B., Javouhey, E., Hemmert, A., Mallet, F., Trouillet-Assant, S., Brengel-Pesce, K., Bartolo, F., Basmaci, R., Boisselier, L., Bouchiat-Sarabi, C., Capella, C., Casalegno, J., Cheynet, V. & 80 others, Compagnon, C., de Cambronne, R. D., Droz, N., Generenaz, L., Gillet, Y., Guichard, A., Hees, L., Mezgueldi, E., Mouton, W., Oriol, G., Ouziel, A., Pachot, A., Pons, S., Portefaix, A., Rebaud, P., Toumi, C., Ader, F., Gaymard, A., Villard, M., Lina, B., Bitker, L., Becker, A., Benech, N., Chauvelot, P., Chidiac, C., Conrad, A., Ferry, T., Miailhes, P., Perpoint, T., Perry, M., Pouderoux, C., Roux, S., Triffault-Fillit, C., Valour, F., Hodane, Y., Chauvelot, L., Chabert, P., Provoost, J., David, G., Folliet, L., Lecam, P., Billaud, G., Bouscambert, M., Escuret, V., Frobert, E., Bal, A., Destras, G., Josset, L., Morfin, F., Munier, C., Valette, M., Venet, F., Garnier, L., Pescarmona, R., Lombard, C., Walzer, T., Adnot, J., Alfaiate, D., Bal, A., Bergeret, A., Boibieux, A., Bonnet, F., Brunel-Dalmas, F., Caire, E., Chiarello, P., Cotte, L., d’Aubarede, C., Durupt, F., Escuret, V., Fascia, P., Fontaine, J., Gaillot-Durand, L., Gillet, M., Godinot, M., Gueyffier, F., Guibert, N., Lahousse, M., Lina, B., Lozano, H. & Makhloufi, D., 1 Jan 2021, In: European Journal of Immunology.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    1 Scopus citations
Your message has successfully been sent.
Your message was not sent due to an error.
If you made any changes in Pure these will be visible here soon.